Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C145 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Wednesday 04/06/22
03:30 PM - 05:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Meredith Wicklund, MD, FAAN
Aging, Dementia, Cognitive, and Behavioral Neurology
Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms. Participants will additionally become familiar with the first ever disease modifying treatment for dementia and its role in clinical practice.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT Introduction Introduction/Opening Remarks
Meredith Wicklund, MD, FAAN
03:30 PM - 03:30 PM PDT Speaker Walk-in Slides
Meredith Wicklund, MD, FAAN
03:35 PM - 04:10 PM PDT Speaker Pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia
Lealani Mae Acosta, MD, MPH, FAAN
04:10 PM - 04:45 PM PDT Speaker Non-pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia
Julio C. Rojas-Martinez, MD, PhD
04:45 PM - 05:20 PM PDT Speaker Disease-modifying Treatment in Dementia
Meredith Wicklund, MD, FAAN
05:20 PM - 05:30 PM PDT Q&A Questions and Answers
Meredith Wicklund, MD, FAAN
Faculty Disclosures
Meredith Wicklund, MD, FAAN The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Lealani Mae Acosta, MD, MPH, FAAN Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Julio C. Rojas-Martinez, MD, PhD The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. Dr. Rojas-Martinez has received research support from Roon, Healthcare. The institution of Dr. Rojas-Martinez has received research support from Amylyx.